Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia

• Published in: Revista Brasileira de terapia intensiva Vol. 34; no. 1; pp. 1 - 12
• Main Authors: Falavigna, Maicon, Stein, Cinara, Amaral, José Luiz Gomes do, Azevedo, Luciano Cesar Pontes de, Belli, Karlyse Claudino, Colpani, Verônica, Cunha, Clóvis Arns da, Dal-Pizzol, Felipe, Dias, Maria Beatriz Souza, Ferreira, Juliana Carvalho, Freitas, Ana Paula da Rocha, Gräf, Débora Dalmas, Guimarães, Hélio Penna, Lobo, Suzana Margareth Ajeje, Monteiro, José Tadeu, Nunes, Michelle Silva, Oliveira, Maura Salaroli de, Prado, Clementina Corah Lucas, Santos, Vania Cristina Canuto, Silva, Rosemeri Maurici da, Sobreira, Marcone Lima, Veiga, Viviane Cordeiro, Vidal, Ávila Teixeira, Xavier, Ricardo Machado, Zavascki, Alexandre Prehn, Machado, Flávia Ribeiro, Carvalho, Carlos Roberto Ribeiro de
• Format: Journal Article
• Language: English; Portuguese
• Published: Brazil Associação de Medicina Intensiva Brasileira - AMIB 01.01.2022
• Subjects: Adrenal Cortex Hormones - therapeutic use; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Brazil; COVID-19 - therapy; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; Oxygen; Special; Thromboembolism; Brazil

Several therapies are being used or proposed for COVID-19, and many lack appropriate evaluations of their effectiveness and safety. The purpose of this document is to develop recommendations to support decisions regarding the pharmacological treatment of patients hospitalized with COVID-19 in Brazil...